Literature DB >> 3191597

Ultrasonic plaque ablation. A new method for recanalization of partially or totally occluded arteries.

R J Siegel1, M C Fishbein, J Forrester, K Moore, E DeCastro, L Daykhovsky, T A DonMichael.   

Abstract

The potential application of ultrasonic energy for ablation of atherosclerotic plaques was studied in human atherosclerotic arteries with continuous and pulsed delivery of energy. With a prototype ultrasonic wire probe (n = 79 segments), there was gross reduction in vascular lesions as well as microscopic disruption of fibrous and calcified plaques. Normal portions of vessels appeared unaffected by the application of ultrasound. The prototype ultrasonic wire catheter ablated calcific deposits in less than 10 seconds. With this probe, all 26 complete atherosclerotic occlusions 0.5-5 cm in length were recanalized irrespective of the presence of calcium. Twenty-four of the segments were reopened in less than 20 seconds. By light microscopy, the site of plaque ablation was smooth, concave, and conformed to the shape of the probe tip. In 17 samples, there was evidence of thermal injury, and in six of the 79 samples studied with the prototype probe, there was vascular perforation. No vascular perforation occurred without thermal damage, when pulsed (rather than continuous) ultrasonic energy was used (n = 40) or when the duration of application was less than 30 seconds, with power output less than 25 W and with the probe oriented parallel to the wall (n = 26). Thus, by modifying the duration, mode, and magnitude of the ultrasonic power output, thermal injury and vascular perforation may be avoided. In vivo intra-arterial ultrasonic angioplasty of a canine chronic femoral fibrocellular occlusion was also performed. A preliminary in vivo study demonstrated feasibility of the percutaneous application of intra-arterial ultrasonic recanalization. Thus, ultrasonic energy appears to have potential as a method for ablation of occlusive atherosclerotic plaque.

Entities:  

Mesh:

Year:  1988        PMID: 3191597     DOI: 10.1161/01.cir.78.6.1443

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Enhancement of fibrinolysis in vitro by ultrasound.

Authors:  C W Francis; P T Onundarson; E L Carstensen; A Blinc; R S Meltzer; K Schwarz; V J Marder
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Possibilities of ultrasound catheters.

Authors:  B Breyer; B Ferek-Petric
Journal:  Int J Card Imaging       Date:  1991

3.  Intravascular ultrasound imaging for guidance of atherectomy and other plaque removal techniques.

Authors:  P G Yock; P J Fitzgerald; K Sudhir; D T Linker; W White; A Ports
Journal:  Int J Card Imaging       Date:  1991

4.  Influences of microbubble diameter and ultrasonic parameters on in vitro sonothrombolysis efficacy.

Authors:  Michael J Borrelli; William D O'Brien; Eric Hamilton; Michael L Oelze; Jonah Wu; Laura J Bernock; Stephen Tung; Husein Rokadia; William C Culp
Journal:  J Vasc Interv Radiol       Date:  2012-10-27       Impact factor: 3.464

Review 5.  Perspectives on the role of ultrasonic devices in thrombolysis.

Authors:  Shaul Atar; Uri Rosenschein
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

6.  Effectiveness and safety of ultrasonic atherosclerotic plaque ablation: in vitro investigation.

Authors:  C Müller-Leisse; T Schmitz-Rode; U Böhm; S Biesterfeld; G Hollweg; C J Kirkpatrick; R W Günther
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Sep-Oct       Impact factor: 2.740

7.  Therapeutic application of ultrasound: contrast-enhanced thrombolysis in acute ST-elevation myocardial infarction; the Sonolysis study.

Authors:  J Slikkerveer; G Veen; Y Appelman; N van Royen; O Kamp
Journal:  Neth Heart J       Date:  2011-03-08       Impact factor: 2.380

8.  Ultrasonic actuation of a fine-needle improves biopsy yield.

Authors:  Emanuele Perra; Eetu Lampsijärvi; Gonçalo Barreto; Muhammad Arif; Tuomas Puranen; Edward Hæggström; Kenneth P H Pritzker; Heikki J Nieminen
Journal:  Sci Rep       Date:  2021-04-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.